Arialytics is a quantitative investment research firm. We are developing advanced machine cognition and quantitative technologies that support portfolio construction and the development of professional investment strategies.
Scientific Research and Portfolio Construction
Our aim is to develop superior portfolio solutions that maximize outcomes and minimize return distribution uncertainty through the discovery of novel strategies, empirically proven over market cycles. Central to our research approach is a deep commitment to eliminating analytic bias with rigorous scientific methods.
Novel Investment Strategies
We focus on discovering novel investment strategies that seek to achieve desired outcomes. We work with professional investment organizations including registered investment companies, pension funds, sovereign wealth funds, endowments and family offices.
Systematic Investment Management
We’re at the forefront of harnessing new tools including advanced econometrics, artificial intelligence, big data, and dynamic prediction to amplify our research capabilities and enhance their scientific validity. These and other technologies help us identify risks and extract investable insight from noisy market data and changing market conditions.
David is the Managing Director of Arialytics and leads our research initiatives. Arialytics was founded in 2010 in response to demand for sophisticated quantitative trading strategies that are based on machine cognition and scientifically valid research methods. David brings expertise in artificial intelligence, prediction, portfolio construction and alpha discovery to Arialytics.
Prior to moving to Finance, David was a Principal at The Boston Consulting Group (BCG), where he advised executives at some of the world's leading asset management and pharmaceutical firms. In the late 1990s and early 2000s David led the development of advanced internet search technologies, founding and serving as CEO of an artificial intelligence driven search engine venture overseeing over 40 researchers and employees. He has also done pioneering work predicting drug trial outcomes and the prices of new generations of high-tech goods.
David holds an MBA degree from the University of Chicago, Booth School of Business where he was a Sara Lee Fellowship recipient and was fortunate to have had three lecturers who have received the Nobel Prize in Economics. He holds a BA in Economics, magna cum laude, from SUNY Buffalo where he was an Honors Scholar.
Mark Putrino, CMT
Mark is a Director of Arialytics and leads business development. Mark brings two decades of buyside trading experience to Arialytics. Prior to joining, he established Bullshead Trading Analysis (BHT), an independent market equilibrium research provider. Mark spent fifteen years as the head of trading at three different Investment managers. From 2010 through 2016, he was the Head of Trading at Thomson, Horstmann and Bryant Inc., an investment advisor specializing in microcap equities. From 2005 through 2009, he was the Head of Trading at Lapides Asset Management LLC, a Greenwich CT based advisor and hedge fund.
From 1999 until 2005 Mark was the Head of Trading and Chief Market Technician at Lombardia Capital Partners. Earlier in his career, Mark was a senior Equity Trader at SAC Capital, and a Market Maker at Gabelli & Company Institutional Brokerage.
Mark holds an MBA degree from the Stern School of Business at New York University. While there, he studied under Nobel Prize winning economist Robert Solow. Mark holds a BA in Economics from the University of Connecticut, is a Chartered Market Technician (CMT), and a member of the Market Technicians Association since 1999.